Webinar Expert Roundtable: Real World Process Intensification

On-Demand Webinar | Expert Roundtable: Real-World Process Intensification Strategies for Smarter Biomanufacturing

Facing inflation, biosimilar competition, and pressure to reduce drug costs below $50 per gram, the biopharma industry is turning to process intensification (PI) to stay competitive. In this expert panel, leaders in upstream, downstream, automation, and manufacturing share proven strategies to modernize legacy facilities, reduce footprint and energy use, and boost yield and flexibility. Learn how Sartorius and its collaborators are implementing PI today — with real-world case studies and practical guidance to build future-ready operations that deliver more without building more.

What You Will Learn:

Discover how process intensification helps modernize legacy infrastructure and boost output—without expanding your footprint
Learn practical tips on implementing PI upstream and downstream—including automation, digital tools, and modular upgrades
Explore case studies showing how others have cut costs and boosted yield, and intensified processes at scale

Clear form data

Please Complete the Form

First Name *

Last Name *

Email *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form to Watch

Geert Lissens

Head of Product Management

As Head of Product Management at Sartorius since 2016, Geert Lissens drives innovation and strategic development for downstream systems and instruments. He has more than 20 years of experience in bioprocessing spanning technical, sales, marketing, and product leadership roles.

Kevin Brower

Global Head, Purification Development, Sanofi

Kevin Brower is Global Head of Purification Development in the Mammalian Platform. His team performs process development for antibodies, multi-specifics, enzymes, and antibody drug conjugates, as well as technology development in continuous manufacturing, high throughput, PAT, and modeling.

Abijor Bhori

Associate Vice President, Head of Purification Process Development, Enzene

Abijar Bhori leads the Purification Process Development and Drug Product Development teams at Enzene. His expertise includes purification process development of both small and large biomolecules, process characterization, scale-up, and technology transfer to manufacturing sites.

David Garcia

Director of the Scientific Office in Drug Substance Development, Novartis Pharma AG

David Garcia Münzer is Director of the Scientific Office in Drug Substance Development at Novartis Pharma AG. Since joining Novartis in 2015, David has focused on the development of innovative technologies for portfolio projects like integrated continuous biomanufacturing.

Tiago Matos

Associate Principal Scientist in Bioprocess Drug Substance and Commercialization, Merck

Tiago Matos is an Associate Principal Scientist in Bioprocess Drug Substance and Commercialization at Merck, with over a decade of experience in the pharmaceutical industry. At Merck, he drives innovation in process development, smart processing, and advanced control strategies.